Skip to content

Randomized Controlled Trial for Retractor SPONGE Evaluation in Laparoscopic Colorectal Surgery

The Impact of Use of a Retractor Sponge on Duration of Hospital Stay and Perioperative Complications in Patients With Colorectal Cancer Undergoing Laparoscopic Colorectal Surgery: the SPONGE Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02574013
Acronym
SPONGE
Enrollment
188
Registered
2015-10-12
Start date
2015-11-30
Completion date
2020-12-31
Last updated
2019-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Surgery

Brief summary

To achieve an adequate visual working field during laparoscopic colorectal surgery without disturbance of the small intestine, patients are positioned in Trendelenburg position. This position results in hemodynamic changes which may increase the risk of cardiopulmonary complications and prolonged hospital stay. Recently, an intraoperative retractor sponge was introduced as alternative for the Trendelenburg position during laparoscopic surgery.

Detailed description

Objective: To study the impact of use of an intraoperative retractor sponge on duration of hospital stay and risk of perioperative complications in patients undergoing laparoscopic surgery for colorectal cancer. Study design: Randomized controlled trial, nested within a prospective cohort according to the 'cohort multiple randomized controlled trial' (cmRCT) design (clinicaltrials.gov NCT02070146). Study population: Patients with colorectal cancer who undergo laparoscopic sigmoid of rectal resection, and who have given informed consent to be offered experimental interventions within the prospective cohort. Patient who require open surgery or patients with benign colorectal diseases are excluded for this study. Intervention: Intraoperative use of the retractor sponge versus usual care, i.e. the Trendelenburg position. Main study parameters/endpoints: The primary endpoint is hospital stay. Secondary objectives are operation time, blood-loss, fluid balance, body temperature, oxygen therapy and postoperative complications. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The study will be conducted according to the cohort multiple Randomized Controlled Trial (cmRCT) design. Within the PLCRC cohort, we will identify all patients who are eligible for the experimental intervention and who have given informed consent to be invited for future experimental interventions. From this sub cohort, we will randomly select a group of patients to whom we will offer surgery with use of the retractor sponge, which they can accept or decline. Eligible patients from the sub cohort who were not randomly selected will undergo standard treatment, i.e. surgery in Trendelenburg position. We do not expect adverse events in patients in the intervention arm.

Interventions

DEVICEEndoractor®

Endoscopic sponge for retraction of small intestine

Sponsors

St. Antonius Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. histologically confirmed distal colon (sigmoid) or rectal cancer, 2. planned for elective laparoscopic colorectal surgery, 3. performance status WHO 0-2 4. broad consent for randomization within ProspectIve data coLlection initiative on ColoRectal Cancer (PLCRC) cohort

Exclusion criteria

1. patients planned for open colorectal surgery or emergency colorectal surgery 2. patients with inadequate understanding of the Dutch language in speech and/or writing.

Design outcomes

Primary

MeasureTime frameDescription
Length of hospital stayParticipants will be followed for the duration of hospital stay, an expected average of 1 weekDischarge is based on a checklist

Secondary

MeasureTime frameDescription
Blood-loss (ml)Intraoperative
Fluid balance (L)Intraoperative
Operation time (minutes)Intraoperative
Postoperative oxygen therapyBaselineNumber of participants in need for oxygen therapy leaving the recovery room.
Postoperative complicationsParticipants will be followed for the duration of hospital stay, an expected average of 1 weekIncluding cardiac, pulmonary, surgical, infectious and thrombovascular events
Postoperative body temperatureBaseline

Countries

Netherlands

Contacts

Primary ContactAnke B Smits, MD PhD
a.smits@antoniusziekenhuis.nl0031883201919
Backup ContactHelena M Verkooijen, MD PhD
h.m.verkooijen@umcutrecht.nl0031887559575

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026